Emerging application for stimuli-sensitive materials in theranostic
Keywords:
nanomaterial’s, nanotechnologies, theranostics, stimuli, treatmentAbstract
Upsurge appropriate to novel nanomaterial’s and nanotechnologies has enlivened specialists who are making progress toward planning more securemore proficient medication conveyance frameworks inasmuch as malignant growth treatment. Improvements responsive nanomaterial offeredchoice towards plan controllable medication conveyance framework by virtue appropriate to its spatiotemporally controllable properties. Furthermore, outside improvements (light, attractive field and ultrasound) could form into theranosticapplications inasmuch as customized medication use as result appropriate to their one appropriate to kind qualities. Include this survey, we give concise outline aboutcritical advances difficulties appropriate to certain external stimuli responsive frameworks that have been broadly researched include drug conveyance theranostics insidemost recent couple appropriate to years.
Downloads
References
Chen Q, Ke H, Dai Z, et al. Nanoscaletheranostics for physical stimulus-responsive cancer therapies. Biomaterials 2015;73:214–230.
Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J NatlCancer Inst 1998;90:889–905.
El-Sayed SL, Shape AM. and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int RevPhysChem 2000;19:409–453.
Fleige E, Quadir MA, Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv DrugDeliv Rev 2012;64:866–884.
Gao S, Zhang L, Wang G, et al. Hybrid graphene/Au activatabletheranostic agent for multimodalities imaging guided enhanced photothermal therapy. Biomaterials 2015;79:28–54.
Hu Q, Katti PS, Gu Z. Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale 2014;6:12273–12286.
Ji H, Sun H, Qu X. Antibacterial applications of graphenebasednanomaterials: recent achievements and challenges. Adv DrugDeliv Rev 2016;25:857–861.
Jiang D, Gao X, Kang T, et al. Actively targeting d-alphatocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer. Nanoscale 2016;8:3100–3118.
Jin CS, Cui L, Wang F, et al. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy. AdvHealthc Mater 2014;3:1240–1249.
Khadka P, Ro J, Kim H, et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 2014;9:304– 316.
Kim H, Chung K, Lee S, et al. Near-infrared light-responsive nanomaterials for cancer theranostics. Wiley Interdiscip Rev NanomedNanobiotechnol 2016;8:1022–1098.
Kim J, Santos OA, Park JH. Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. J Control Release 2014;191:98–104.
Kou L, Sun J, Zhai Y, et al. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci 2013;8:1–10.
Lehner R, Wang X, Wolf M, et al. Designing switchable nanosystems for medical application. J Control Release 2012;161:307–316.
Liu Y, Wang W, Yang J, et al. pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J Pharm Sci 2013;8:159–167.
Lovell JF, Jin CS, Huynh E, et al. Porphysomenanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011;10:324–332.
Master A, Livingston M, Sen Gupta A. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release 2013;168:88– 102.
Meng Z, Wei F, Wang R, et al. Tumor therapy: NIR-laserswitched in vivo smart nanocapsules for synergic photothermal and chemotherapy of tumors. Adv Mater 2016;28(2):245–253.
Pang B, Zhao Y, Luehmann H, et al. (64)Cu-Doped PdCu@Au Tripods: a multifunctional nanomaterial for positron emission tomography and image-guided photothermal cancer treatment. AngewChemInt Ed Engl 1962;1:246–264.
Park JH, Von Maltzahn G, Ong LL, et al. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.Adv Mater 2010;22:880–885.
Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 1986;2:111– 137.
Shapira A, Livney YD, Broxterman HJ, et al. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Drug Resist Updat 2011;14:150–163.
Tian Q, Tang M, Sun Y, et al. Hydrophilic flower-like CuS superstructures as an efficient 980 nm laser-driven photothermal agent for ablation of cancer cells. AIDS Care 2011;23:3542–3547.
Toh MR, Chiu GNC. Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing. Asian J Pharm Sci 2013;8:88–95.
Wong BS, Yoong SL, Jagusiak A, et al. Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev 2013;65:1964–2015.
Zha Z, Yue X, Ren Q, et al. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells.Adv Mater 2013;25:777–782.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
